New phenotype of severe neonatal episodic laryngospasm due to a missense mutation in SCN4A: A case report and literature review.

Qiong Xi, Lu Yi, Wenjuan Zhou, Jia Chen, Zuocheng Yang

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2022;46(12):1430-1436

PMID: 35232915

Abstract

Severe neonatal episodic laryngospasm (SNEL) is an ion channel disease characterized by recurrent life-threatening myotonia of respiratory muscle due to mutations in the voltage-gated sodium channel genes. Here we reported a newborn manifested as paroxysmal cyanosis and limb myotonia after birth. The neonate also developed muscle hypertrophy and stunted growth during the follow-up. Whole exome sequencing confirmed c.2395G>A, p.Ala799Thr heterozygous mutation of SCN4A Carbamazepine was found to be effective on treating the disease. This case expands our understanding of the phenotype resulting from SCN4Amutations. By summarizing the characteristics of reported 16 cases in SNEL,we found they were mainly in the p.G1306E mutation. The common symptoms were upper airway muscle stiffness and feeding difficulties during neonates.When grow up, most patients have different degrees of recurrent attacks of myotonia and progressed muscle hypertrophy. Some of them have athlete-like special faces but all showed myotonic discharge in eletromyogram.

Address: Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha 410013, China. [email protected].; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha 410013, China. [email protected].; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha 410013, China.; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha 410013, China. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.